title: kConFab: a familial breast cancer consortium facilitating research and translational oncology.
abstract: In 2005, 100,514 Australians were diagnosed with cancer, and over 10,000 of these cancers will be due to heritable causes. The impact of familial cancer by definition extends beyond the individual, affecting tens of thousands of parents, siblings, and children. The study of familial cancer causes has arguably made the greatest single contribution to our understanding of cancer biology. This knowledge is used clinically to guide investment in screening and prevention, as well as being translated into new treatments.
authors: Research Department, PeterMacCallum Cancer Centre, St Andrew's Place, East Melbourne, Victoria 3002, Australia. heather.thorne@petermac.org
authors: Heather
authors: H
authors: Thorne
authors: Gillian
authors: G
authors: Mitchell
authors: Stephen
authors: S
authors: Fox
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D001315:Australia / Q000453:epidemiology; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000453:epidemiology / Q000235:genetics*; D002986:Clinical Trials as Topic / Q000379:methods / Q000639:trends; D005260:Female; D019398:Genes, BRCA1 / Q000187:drug effects; D024522:Genes, BRCA2 / Q000187:drug effects; D020022:Genetic Predisposition to Disease; D006579:Heterozygote; D006801:Humans; D008495:Medical Oncology / Q000379:methods / Q000458:organization & administration / Q000639:trends; D009154:Mutation; D009520:New Zealand / Q000453:epidemiology; D018579:Patient Selection; D057170:Translational Research, Biomedical / Q000379:methods / Q000639:trends
chemical_list: D000970:Antineoplastic Agents